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Abstract
Membrane fusion and fission underlie two limiting steps of enveloped virus replication cycle: access to the interior of the host-cell (entry) and
dissemination of viral progeny after replication (budding), respectively. These dynamic processes proceed mediated by specialized proteins that
disrupt and bend the lipid bilayer organization transiently and locally. We introduced Wimley–White membrane-water partitioning free energies of
the amino acids as an algorithm for predicting functional domains that may transmit protein conformational energy into membranes. It was found
that many viral products possess unusually extended, aromatic-rich pre-transmembrane stretches predicted to stably reside at the membrane
interface. Here, we review structure–function studies, as well as data reported on the interaction of representative peptides with model membranes,
all of which sustain a functional role for these domains in viral fusion and fission. Since pre-transmembrane sequences also constitute antigenic
determinants in a membrane-bound state, we also describe some recent results on their recognition and blocking at membrane interface by
neutralizing antibodies.
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Membrane fusion and fission can be considered as ener-
getically unfavorable reactions that involve hundreds of lipid
molecules with no change in covalent bonding. These complex
physiological reactions proceed coupled to the basic processes
of local rupture (exposure of the hydrophobic interior) and
deformation (bending) of lipid bilayers (reviewed in Refs.
[1,2]). Enveloped animal viruses rely on the fusogenic activity
of membrane integral surface glycoproteins to enter and infect
their host-cells [3–7], while fission is required for pinching-off
of newly assembled virions [1]. Membrane fission is also
operational intracellularly all along virus infectious cycles [8].
For example trafficking of viral proteins during assembly at the
plasma or intracellular membranes and perhaps during intra-
cellular translocation of the capsid complexes is dependent on
this process [9].
Fusion protein machinery delivers energy in order to perform
a series of jobs, including bringing the membranes into close
contact and the sequential formation of only-lipid (“stalks”) and
lipid-aqueous connections (“fusion pores”) [10–14]. Although
these proteins share little sequence homology even between
members of the same family, evolutionary convergence has
produced a number of common features [1,7,12]: functional
priming at the cell surface through proteolytic processing, oli-
gomeric organization (homotrimers of heterodimers in most
cases), activity localized into ecto and transmembrane domains
of the integral subunit, and the presence of a fusion peptide
(FP), a highly conserved, hydrophobic domain, usually located
at or close to the free amino-terminus of the integral subunit.
Viral fusogenic function, on the other hand, has been as-
sembled within two structurally divergent scaffolds [4,12,15].
Class I fusion proteins are all characterized by their capacity to
fold into a highly stable 6-helix bundle (6-HB). In this “hairpin-
like” trimeric structure three helices pack in the reverse direction
against hydrophobic grooves outside a triple-stranded coiled-
coil, so that the ectodomain amino- and carboxy-termini are
placed at the same end of the molecule. It is generally thought
that amino-terminal FP sequences insert into the target cell
membrane in a “pre-hairpin” stage [16–18]. Subsequent pro-
duction of the 6-HB would therefore induce close apposition of
the viral and cell membranes anchored through the transmem-
brane domain (TMD) and the FP, respectively. In contrast, class
II proteins are composed of antiparallel β-sheet structures and
possess internal FPs [4,12,15,19]. Despite these differences,
class II proteins have evolved into structures capable of trig-
gering fusion following a mechanism essentially similar to that
of class I proteins [15,19], namely, FP insertion into the targetmembrane and folding into a low-energy trimer that brings into
contact TMD- and FP-anchored membranes.
Thus, protein conformational energy, such as that released
upon 6-HB formation, must be coupled with membrane merger
by means of membrane-inserting specialized domains. In this
reviewwewill not address the FPs, since these force-transmitting
domains, together with additional assistant elements scattered
along the ectodomain sequences, have been recently subject of
thorough revision in these series [17,18,20]. Here, we will speci-
fically focus on the domains that precede transmembrane anchors
in viral proteins promoting fusion–fission. These sequences have
been defined as distinct domains according to their tendency to
partition from water into the membrane interface (designated as
“pre-transmembrane” domains, PreTM), and also attending to its
implication in fusion and viral neutralization processes (desig-
nated as “membrane-proximal external regions”, MPER).
Since a hydrophilic, flexible, structurally irregular PreTM
linker might keep the 6-HB far from the close contacting dehy-
drated areas required for membrane fusion initiation (as far as
70Å apart from the viral membrane in the case of HIV), it has
been argued that force transmission requires the establishment of
contacts between this element and the viral membrane [21].
Moreover, the proximal location of PreTM covalently linked to
TMD ensures the high effective concentrations favoring its
insertion into membranes. Accordingly, the capacity of PreTM
regions for inserting intomembranes has been extensively studied
in model vesicular systems using representative synthetic pep-
tides. These studies further suggest a putative role of membrane-
inserted PreTMs as promoters of lipid bilayer destabilization. In
the following sections we review experimental results, obtained
in different viral systems, all of which sustain the functional
activity of viral PreTMs in fusion–fission, either by transmitting
protein conformational energy into membranes, and/or by per-
turbing lipid bilayer integrity.
2. Hydrophobicity-at-interface: a tool for unraveling viral
PreTM sequences
In previously published review work we described the ap-
plication of Wimley–White (WW) scales to the detection of
viral sequences that show tendency to partition into membrane
interfaces [22]. The analysis was performed with the premise
that glycoprotein globular ectodomains behave as non-
constitutive membrane proteins, i.e., initially soluble species
capable of inserting spontaneously into uncharged cell target
membranes in the course of the fusion process. Wimley and
White calculated the water-to-membrane interface transfer free
energies for each amino acid in the context of unfolded peptide
Fig. 1. Interfacial PreTM domains in viral fusion proteins as predicted by the combined WW–KD hydrophobicity analysis. A) Membrane-proximal external and
transmembrane regions of HIV-1 gp41. Hydropathy (mean values for a window of 11 amino acids) was plotted according to the Kyte–Doolittle hydropathy index
(black lines), Wimley–White interfacial hydrophobicity (top panel, red-continuous trace) or Wimley–White interfacial moment (bottom panel, red-dotted line).
B) Predicted location of gp41 AIS-PreTM (red cylinder) at the viral membrane interface. The cryoET density map contour of SIV envelope spike is indicated by the
gray surface [36]. C) Analyses of membrane-proximal external and transmembrane regions in selected examples.
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lated as a hydrophobicity scale that compiles the energetic
components dictating initial partitioning of sequences into
membranes, specifically when this occurs in the absence of
repulsive or attractive electrostatic interactions. As compared to
classical hydropathy indexes based on bulk-phase partitioning of
side chain alone, WW “interfacial hydrophobicity scale” takes
into account the effect of the membrane interface on partitioning
and includes the energy cost of peptide bond partitioning into it.
This originates important differences in residue hydrophobicities,
aromatic residues, namely Phe, Tyr and Trp, appearing to be the
most hydrophobic ones when located at membrane interfaces.
Hydrophobicity-at-interface WW scale was first applied to
HIV-1 and Ebola FPs with the aim of confirming their tendency
to spontaneously partition from water into the bilayer interface
[25–27]. Features of HIV-1 and Ebola FP sequences as potential
membrane anchors were readily evident upon Kyte–Doolittle
(KD) hydropathy analysis [28]. Thus, KD and WW hydropathy
plots displayed positive peaks coincident with the FP sequences.
However, a further analysis combining both scales disclosed
segregated peaks at the membrane-proximal region of HIV-1
gp41 ectodomain (Fig. 1A and Refs. [29,30]). When compa-
red to the KD peak spanning gp41 TMD, the positive ma-
ximum detected by WW was shifted 15–20 residues towards the
N-terminus (continuous red plot in top panel of Fig. 1A). The
combined WW–KD analysis thus suggested the existence of
a wide nonpolar region (approximately 40–50 residues long)
at the C-terminus of the gp41 ectodomain (Table 1). This
region would be segmented into two domains: one, position-
ed somewhat farther from the protein C-terminus (residues
664–683 in HIV-1), which would remain stably inserted within
the membrane interface (designated as PreTM [29]), and ano-
ther one located closer to the C-terminus that constitutes the
TMD.
Further development of the WW analysis included the cal-
culation of the hydrophobic-at-interface moment [21,31]. Hyd-
rophobic moments measure the periodicity of residue distribution
along the secondary structure elements [32,33]. Preferential ori-
entation of the hydrophobic residues towards one face of the
structure element has been proposed to favor hydrophobic inter-
actions between protein structural components and between
membranes and protein sequences. Computation of the hydro-
phobic moment using the membrane interface-to-water transfer
free energies (ΔGiwu) for each amino acid [23] suggested thatTable 1
AIS-PreTM-TMD motifs in selected examples of viral fusion proteins
Protein a
HIV-1 Env 658-Q
SARS Co-S 1181-
Ebola GP 639-G
FIV Env 760-G
VSV-GP 449-N
a Numbering based on the HIV-1 HXB2, Ebola Zaire, FIV Petuma, SARS-CoV U
b Sequences in boxes and bold span, amphipathic-at-interface and hydrophobic-a
sequences in italics denote hydrophobic transmembrane sequences estimated accord
displayed in Fig. 1.gp41 PreTM can be elongated at the N-terminus to include a
stretch whose face shows strong affinity for membranes, if folded
into an α-helix (Fig. 1A red-dotted plot in bottom panel). It must
be noted that this amphipathic-at-interface stretch could not be
detected when KD or Eisenberg scales were used [21]. Moreover,
the moment peak shown in Fig. 1A (bottom panel) was present in
different HIV-1 isolates and in other lentiviruses thereby sug-
gesting that the N-terminal segment of gp41 PreTM consists in a
conserved amphipathic-at-interface sequence, recently designated
as AIS [34].
In summary, the hydrophobicity analysis in Fig. 1A predicts
the existence of a gp41 region anchored to the viral membrane
through an interfacial sequence, amphipathic at its N-terminus,
which is followed by the fully hydrophobic transmembrane
helix (Table 1 and cartoon in Fig. 1B). The physiological rele-
vance of gp41 AIS-PreTM-TMD motif has recently received
support from structural studies in intact SIV and HIV virions
[35,36]. Cryoelectronmicroscopy tomography has disclosed stalk
regions that project as “legs” from the trimeric Env complex, with
their “feet” just above the plane of the envelope (tripod-like
structure, contour in Fig. 1B) [36,37]. This observation would be
consistent with native Env AIS-PreTM monomers being located
at the viral surface, and inserted in parallel to the external mem-
brane monolayer plane.
Extension of WW analysis to envelope spikes of several
virus families suggests that an interfacial location of membrane-
proximal external regions might be a common structural feature
[29,38]. Fig. 1C and Table 1 provide several examples that
illustrate different outcomes of the combined WW–KD hydro-
phobicity analysis. The presence of a hydrophobic-at-interface,
aromatic-rich sequence within the fusogenic S2 subunit of
SARS coronavirus spike S was already reported [39,40]. The
analysis in Fig. 1C adds to this finding the existence of a pattern
similar to that previously described for HIV-1 gp41 (panel A).
The plots thus indicate that the fully hydrophobic-at-interface
SARS S2 PreTM sequence can be elongated at the N-terminus
to include an amphipathic-at-interface stretch (see also Table 1).
A comparable but different situation occurs in the case of the
Ebola fusion protein. Ebola GP contains within the membrane-
proximal region of the GP2 ectodomain an approximately 10aa-
long sequence showing a high tendency to partition into
membrane interfaces (Ref. [31], see also Table 1). However,
computation of the hydrophobic-at-interface moment for this
element reflects the existence of a longer amphipathic-at-Sequence b
ELLELDKWASLWNWFNITNWLWYIKLFIMIVGGLVGLRIVFAVLSVVNR-707
DLQELGKYEQYIKWPWYVWLGFIAGLIAIVMVTILLCCMTSCCSCL-1226
DNDNWWTGWRQWIPAGIGVTGVIIAVIALFCICKFVF-676
KTGIQQLQKWEDWVRWIGNIPQYLKGLLGGILGIGLGVLLLILCLPTLVD-810
PIDFVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIYLYIKLK-493
rbani and VSV Indiana, strains/serotypes.
t-interface domains, respectively, as determined by WW algorithm. Underlined
ing to KD algorithm. The range of each sequence has been inferred from plots
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(Table 1).
Finally, the retroviral FIV Env and vesiculoviral VSV-GP
spike sequences serve to illustrate an additional case. Both
PreTMs are characterized by negligible mean interfacial hydro-
phobicity. The presence of several conserved Trp-s within fu-
sogenic FIV gp36 subunit's membrane-proximal sequence was
previously noted [41,42]. These hydrophobic-at-interface resi-
dues are inter-dispersed with helical periodicity by charged
residues that bear the lowest tendency to partitioning into
membrane interfaces (Table 1). Similarly, aromatic residues at
the VSV G PreTM are intervened by stretches with low pro-
pensity for partitioning (Table 1 and Ref. [43]). As a result, in
both cases the mean hydrophobicity is low and interfacial mo-Fig. 2. Hydrophobicity-at-interface analysis of gp41 PreTMmutants. A) Gp41 PreTM
domains disclosed when mean hydrophobicity values are calculated for a window of 5
partitioning (left) or peak intensity ratio (right) and fusogenicity (average number of
panel correspond to peak 1/peak 2 intensity ratios as obtained from hydropathy-at-in
indicate values not correlating with the represented linear regressions. C) Effect WW
plots (window of 5 amino acids) for the PreTM-TMD regions (amino acids 660–720 i
A. Fusion index as in previous panel. Right: Membrane fusion induced in
DKAASLWNAFNITNALWYIK (black circles) and DKAASLANAFNITNWLWYI
A and W(1–3)A mutants, respectively. Final extents (percentages after 30 min) of int
mol ratios in 1-palmitoyl-2-oleoylphosphatidylcholine:cholesterol (1.5:1) vesicles.ment high, reflecting a propensity for interfacial insertion, but
only upon PreTM folding as an α-helix.
In what follows we summarize a series of experimental
results that sustain the involvement of the predicted interfacial
PreTM domains in membrane-rearrangements leading to viral
fusion–fission.
3. Structure–function studies of HIV-1 gp41 PreTM
3.1. Mutational analyses
Mutational analysis of gp41 MPER by Salzwedel and co-
workers [44] provided compelling evidence to support PreTM
involvement in HIV-1 fusion. Deletion of the entire PreTMsequence. Mutated Trp residues are in bold. Bars on top span the two interfacial
amino acids (see panel C). B) Correlation between PreTM overall free energy of
syncytia in the field as reported by Salzwedel et al. [44]). Plotted values in right
terface plots similar to that displayed in panel C. In both panels hollow symbols
hydrophobicity distribution on PreTM function. Left: Hydropathy-at-interface
n Env precursor) derived from the wild-type and mutants W(1,3,4)A andW(1–3)
a vesicular system by DKWASLWNWFNITNWLWYIK (empty circles),
K black squares) peptides, representing PreTM regions of gp160 wt, W(1,3,4)
ervesicular mixing of lipids were determined as a function of the peptide-to-lipid
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to mediate cell–cell fusion without affecting the normal
maturation, transport, or CD4-binding ability of the protein.
This fusion phenotype was also demonstrated for W(1–5)A, a
PreTM mutant devoid of interfacial hydrophobicity by sub-
stituting alanine residues for the five tryptophan residues within
this sequence. Further analysis using a three-color cell–cell
fusion assay [45] confirmed that gp41 lacking PreTM is incap-
able of mediating both membrane-and-volume mixing. Inter-
estingly, the fusion induced by W(1–5)A mutant was blocked at
the stage of non-expanding small fusion pores. This activity is
similar to that exhibited by GPI-linked hemagglutinin (GPI-
HA) of influenza virus [46].
We applied interfacial hydrophobicity to the analysis of the
numerous mutations generated by Salzwedel and co-workers
(Fig. 2 and Ref. [21]). Hydropathy plots of mean values calcu-
lated for a sliding window of 5 amino acids displayed two defined
positive peaks, consistent with a slightly longer PreTM that
encompasses two segregated interfacial subdomains (Fig. 2). The
N-terminal peakwas found to span the conserved amphipathic-at-
interface helix or AIS domain [34]. We observed that a number of
blocking deletions invariably correlated with the ablation and/or
merging of interfacial subdomains [21]. An extension of this
analysis is displayed in Fig. 2B. Overall free energy of partition-
ing (left) and interfacial hydrophobicity distribution (right) was
plotted vs. fusogenicity of N-terminal subdomain Ala mutants.
Free energy of partitioning, computed as the sum of the free
energies of the constituent amino acids, correlated linearly with
activity of most substitution mutants, but displayed significant
activity for ΔGiwu = 0, indicating that favorable PreTM
partitioning into membranes contributes to, but is not essential
for gp41-mediated fusion. In addition, partitioning free energy
cannot account for the fusion-inhibitory effects of scrambled SC7
and W(1–3)A mutations (hollow symbols). The effect of these
mutations on function seems to better correlate with distribution
of hydrophobicity into two subdomains (right panel). When
hydrophobicity-at-interface peak ratios were plotted vs. fusoge-
nicity, a positive correlation was observed for these and other
mutants. This observation supports the functional relevance
of distributing interfacial hydrophobicity into two segregated
subdomains.
A remarkable example of interfacial hydrophobicity dis-
tribution effect is that of W(1–3)A andW(1,3,4)A substitutions,
only differing in the position of one Trp residue (Fig. 2C). WhileFig. 3. Structural features of gp41 PreTM.A)NMR structure of KWASLWNWF-
NITNWLWYIK in DPCmicelles [49] (PDB entry: 1JAU). Aromatic side chains
are displayed. B) X-ray structure of KGWNWFDITNWGKpeptide bound to Fab
4E10 [50] (PDB entry: 1TZG), 2 peptides displaying aromatic side chains have
been oriented to show the interaction in the crystal unit cell. C) CD spectra of
PreTMp (DKWASLWNWFNITNWLWYIK) in DPC (5 mM) micelles (dotted)
and POPC vesicles (continuous trace). Lipid-alone signal was subtracted from
these samples. D) Fourier self-deconvolved infrared spectra of PreTMp incor-
porated into POPC membranes. The peptide was added to vesicles at 1:50 and
1:1000 peptide-to-lipidmol ratios, top and bottom spectrum, respectively. Lipid–
peptide complexes were subsequently isolated from the floating fractions after
ultracentrifugation in D2O buffer. The spectra are not drawn to the same scale to
better show the 1680–1620 cm−1 amide I region. Structures in panels A and B
were rendered with the Swiss-PDB-viewer program.the former mutation abolished gp41-induced fusion, the latter
maintained ca. 70% of wild-type activity. The hydropathy plots
revealed the effect of these mutations on hydrophobicity distri-
bution (left panel). Whereas W(1,3,4)A mutant retained two
hydrophobic-at-interface segments, W(1–3)A showed a single
interfacial domain (left panel). Panel C compares the fusogenic
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in a lipid vesicle system. The peptide corresponding to the fusion-
competent W(1,3,4)A phenotype was as efficient as the wild-
type peptide in fusing lipid vesicles. In comparison, the peptide
representing the fusion-defective W(1–3)A phenotype displayed
lower activity. Thus, fusion measured in a vesicular system sug-
gests that the observed fusion W(1–3)A phenotype might reflect
this mutant's incapacity to induce membrane-restructuring.
3.2. Structural studies
In accordance with the TMD paradigm, PreTM is postulated
to fold within the low-polarity membrane interface environment
adopting a helical conformation [24,47], but also self-aggregate
therein [48]. Structural studies support both possibilities (Fig. 3).
NMR spectroscopy revealed the formation of a well-defined
helical structure for KWASLWNWFNITNWLWYIK peptide
monomers in dodecylphosphocholine micelles (panel A and
Ref. [49]). Four of the five tryptophan residues, as well as the
tyrosine residue, formed a “collar” of aromatic residues along
the axial length of the helix. Nuclear Overhauser effects to the
headgroup and interfacial protons of protonated dodecylpho-
sphocholine confirmed that the aromatic residues are positioned
within the membrane-water interface of a phospholipid bilayer
sustaining a “Velcro-like” interaction. The bulk of the polar
residues is positioned on one face of this structure, with the
hydrophobic phenylalanine side chain on the opposing face,
forming an amphipathic structure.
An additional PreTM atomic structure was obtained from the
resolution of Fab 4E10 (see below) in complex with KGWNW-
FDITNWGK peptide (panel B and Ref. [50]). The bound peptide
also adopts a helical conformation in which residues contacting
the paratope,W672, F673, I675, and T676, map to one face of the
helix. Interaction of two peptide chains in the unit cell showsFig. 4. HIV-1 gp41 PreTMp surface aggregation and correlation with induced memb
Rho-PreTMp quenching (triangles and dotted lines) and PreTMp-induced leakage (
30 min of incubation with vesicles was plotted as a function of the lipid-to-peptidethe close interdigitation of W670 and W678 indole side chains.
Dimers perhaps mimic a low-energy conformation in the intact
gp41 oligomer or reflect a biologically important interaction of
the peptide Trp residues with the viral membrane [50].
Low-resolution structural techniques provide evidence for
the existence of monomeric and multimeric PreTM states in a
membrane environment (panels C and D). CD helical spectrum
of monomeric PreTMp in DPC micelles displayed a [θ]222/[θ]208
ratio b 1 (dotted trace in panel C, see also Ref. [49]). By com-
parison, CD spectrum of PreTMp incorporated into PC vesicles
at a 1:33 peptide-to-lipid mol ratio (continuous trace) resulted in
an increase of the intensity of the positive peak together with a
[θ]222/[θ]208 ellipticity ratio N 1, which supports the existence of
helix–helix interactions such as those described for heterodimeric
coiled-coils and/or transmembrane helical bundles [51–53]. Flu-
orescence data indeed indicated that rhodamine-labeled PreTMp
in lipid vesicles self-associates at the doses used to carry out these
measurements [21,54] (see also Fig. 4).
IR spectroscopy confirmed the presence of helical structures
as both, monomers or multimers in PC membranes (panel D and
Ref. [21]). At the peptide-to-lipid ratio of 1:1000, where the
peptide is most likely monomeric according to the rhodamine
fluorescence data, PreTMp spectrum showed a symmetrical
band at 1653cm− 1 consistent with a canonical α-helix (Fig. 5B).
At the 1:50 ratio where self-association is prominent, the α-helical
band splitted into two components, absorbing at 1656 and
1649 cm−1, besides the presence of a band at 1639 cm−1, as was
postulated previously for coiled-coils [55]. Thus, combined CD
and IR structural data are compatible with the existence of a
monomeric helical structure, prevalent in membranes at low
doses, which would self-associate with increasing membrane
loads.
Finally, it is important to note that the mutagenesis studies by
Salzwedel et al. did not support the requirement of helicalrane-restructuring in lipid vesicles of different composition. The percentage of
circles and continuous lines) and lipid-mixing (squares and dashed lines) after
mol ratio. Final lipid concentration was 100 μM in all cases.
Fig. 5. Inhibition of HIV-1 gp41 PreTMp-induced membrane-restructuring by
Nab 4E10. A) Model for epitope recognition at the membrane interface by Fab
4E10 (Solid ribbons). Space-filled atoms in blue denote hydrophobic-at-
interface residues exposed to solvent in CDR H2 and H3 loops. Atoms in green
belong to bound KGWNWFDITNWGK peptide. Structure, derived from 1JAU
PDB entry, was rendered with the Swiss-PDB-viewer program. B) Inhibition of
ongoing ANTS leakage with Mab4E10. POPC:Chol (2:1) LUV suspensions
(100 μM lipid) were treated with 1 μM PreTMp (arrow 1) and, further
supplemented (arrow 2) with 25 μg/ml of Mab4E10 (black traces). Controls in
absence of antibody are in red. Blue traces correspond to dansyl fluorescence
increase (arbitrary units) upon PreTMp addition. Adapted from Fig. 3 in Ref.
[103]. C) Recognition of PreTMp bound to ELISA plaques (circles), PC:Chol
vesicles (squares) and PC:SPM vesicles (triangles). Inhibition percentages
(Leakage) or percentages of maximal binding (ELISA) were plotted as a
function of Mab4E10 binding site-to-PreTMp mol ratio (i.e., 2 binding-sites per
Ma4E10 molecule).
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role of an α-helical PreTM structure in fusion was tested
by deleting two central nonconserved residues, or substituting
W672 for with proline. These mutations that would destabilize
an α-helical conformation were found to have no significant
effect on gp41 function, therefore arguing against a topological
requirement for a helical structure. However, the reduction of
the fusogenicity of the glycoprotein observed after scrambling
PreTM central residues (mutant SC7) suggests that the cluster-
ing of hydrophobic residues in an α-helical secondary structure
may indeed be important, but not essential, for the function of
this region.
3.3. Membrane interactions of representative peptides
Early definition of HIV-1 gp41 PreTM as a membrane-
inserting domain prompted the comparison of synthetic DKW-
ASLWNWFNITNWLWYIK (PreTMp) and AVGIGALFLGF-
LGAAGSTMGARS (FPp) in their capacities for perturbing
membranes [29,30]. These studies were conducted under the
assumption that PreTM might represent a second FP, i.e., an
additional domain participating in the induction of the viral
membrane perturbations required for fusion. Sustaining this
notion, lower doses of PreTMp were required to induce fusion
and permeabilization of liposomes [29,30]. Moreover, PreTMp-
induced restructuring effects were modulated by the main lipids
existing in the viral envelope (Fig. 4 and Ref. [54]). Aloia and
co-workers [56,57] found in HIV-1 membranes increased Chol-
to-phospholipid molar ratios and high levels of sphingomyelin
(SPM), ca. 2–3 times that of the host-cell surface membranes.
These findings were subsequently confirmed using a lipidomic
approach [58]. It is therefore assumed that the HIV-1 membrane
is enriched in Chol and SPM, an observation that correlates with
the virion selectivity for specific segregated membrane regions
through which virions emerge during maturation [59].
Results displayed in Fig. 4 illustrate the effect of these lipids
on PreTMp-induced leakage and fusion of liposomes. PreTMp
induced leakage from pure PC liposomes at high peptide-to-
lipid ratios (ca. N1:100 mol:mol) concomitant to an increase in
its self-aggregation, as revealed by an increase in the quenching
level of Rhodamine-labeled species from approximately 40 to
80% (PC labeled panel). No significant fusion could be detected
even at the highest doses tested, namely 1:10. Under conditions
that did not significantly affect partitioning, inclusion of SPM or
Chol in POPC membranes had dissimilar effects. SPM sus-
tained the formation of lytic pores even when Rhodamine
indicated quenching levels below 60% (PC:SPM panel). In
contrast, Chol promoted fusion activity under self-aggregation
levels (60–80% rhodamine quenching) also inducing leak-
age (PC:Chol panel). A similar Chol-dependence for PreTMp-
induced vesicle–vesicle fusion was found in experiments
comparing PreTMp with longer derivatives [60].
When the three lipids were combined (PC:SPM:Chol panel)
to emulate conditions putatively existing at the external mem-
brane monolayer of HI virion, high levels of self-aggregation
(rhodamine quenching N80%), concomitant to an enhancement
in fusion and lytic activities were observed at low doses (in the
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disturb occurrence of lateral separation of s0–l0 lipid phases in
these systems, reproduced the high peptide-dose requirements
for leakage as found in pure POPC vesicles and inhibited fusion
[54]. In summary, the quenching efficiency data as a function
of the peptide-dose in LUV suggests that indeed peptide-
aggregates are involved in membrane perturbations, and that
s0–l0 phase-coexistence promotes PreTM clustering at the mol
ratios existing in the HI virion envelope. Thus, these results
support the notion that the PreTM domain aids in the clustering
of gp41 within the HIV-1 envelope, and in destabilization of the
bilayer architecture at the loci of fusion.
The existence of a direct interaction between Chol and
PreTM domain was already posited by Salzwedel et al. [44].
PreTM carboxy-terminal LWYIK sequence was later identified
as a potential “cholesterol recognition/interaction amino acid
consensus” (CRAC) by measuring the binding to cholesterol of
a series of gp41-derived sequences fused to maltose binding
protein [61]. Recently reported experimental evidence and
modeling studies provide the physicochemical grounds for a
direct interaction of PreTM-CRAC with Chol [62–64]. PreTM–
Chol interaction would be based on two capacities of CRAC
sequence, namely, wrapping and blocking of the interfacial
cholesterol OH group by H-bond interactions, and stacking of
aromatic side chains with A ring of cholesterol. This interaction
model has been proven through site-directed mutagenesis [63].
A conservative L679I substitution, which otherwise reduces the
interaction of CRAC-representative peptides with Chol, result-
ed in a significant attenuation of Env fusogenicity measured in a
cell–cell fusion assay. Thus, these results established a direct
link between capacity to bind Chol-rich domains and biological
activity.
In conjunction, vesicle perturbation assays and calorimetry
determinations suggest that a PreTM–Chol complex might form
at the interface of the external viral membrane monolayer with
the potential of inducing membrane perturbations upon self-
assembly [54,62,63]. However, as discussed by Epand [64], the
fact that L679I mutation did not completely abolished gp41
function posits the possibility that a fraction of the fusion
activity measured in cells is not dependent on PreTM–Chol
interactions. Sustaining the notion that Chol-dependent mem-
brane perturbations induced by PreTM are not absolutely
required for gp41-induced cell–cell fusion, an Env construct
bearing FP blocking mutation and functional PreTM did not
destabilize the plasma membrane upon receptor/co-receptor
engagement [65]. Conversely, activated Env with functional FP
but deleted PreTM was able to permeabilize the plasma mem-
brane of expressing cells.
4. Studies on viral PreTM domains involved in membrane
fusion
A PreTM domain detected within gp36 fusogenic subunit
has been suggested to play a functional role in FIV entry
[41,42,66]. A synthetic peptide modeled on such motif inhibited
FIV replication very efficiently, most likely by blocking entry
[66]. In a later report, 11 mutated clones having the Trp-richmotif scrambled or variously deleted or substituted were pro-
duced and evaluated in their capacity of infecting susceptible
cells [41]. The functional effects of conserved Trp mutations
were analyzed on assembled virions. The viral particles gene-
rated by the constructs having the Trp motif deleted, scrambled,
or Ala substituted at two or three Trp positions were indeed
replication-incompetent. In the latter mutants infection was re-
stored by providing an independent source of intact FIV
envelope glycoproteins or by addition of the fusing agent poly-
ethylene glycol, thus indicating that their defect resided pri-
marily at the level of cell entry. The fact that FIV PreTM was
functionally active in fusion was supported by results of another
site-directed mutagenesis study [42]. In this case, the W(1–3)A
Env protein showed similar levels of expression and processing
as the wild-type, but was completely defective in forming syn-
cytia. It was concluded that this region must be critical for fusion
by FIV Env and that the presence of tryptophans is required for
this property.
The high degree of conservation observed upon sequence
alignment of envelope glycoprotein (G) MPERs from several
different vesiculoviruses suggested that PreTM might be also
important for VSV G function. This was confirmed by Whitt
and co-workers [43,67,68] who showed the involvement of this
domain in VSV fusion and budding (see next section). Deletion
of the 13 stem amino acids (N449 to W461) that span the VSV
AIS domain (Table 1) dramatically reduced cell–cell fusion
activity and reduced virus infectivity approximately 100-fold
[43]. However, mutation of conserved aromatic residues res-
ponsible for amphipathicity (W457, F458, and W461) either
singly or together had only modest effects on cell–cell fusion
activity. Notably, PreTM-TMD-cytoplasmic tail constructs (GS)
expressed in cells could also potentiate the membrane fusion
activity of heterologous viral fusion proteins [68]. For some
fusion proteins, there was as much as a 40-fold increase in
syncytium formation when GS was coexpressed compared to
that seen when the fusion protein was expressed alone. Fusion
potentiation by GS was not protein specific, since it occurred
with both pH-dependent as well as pH-independent fusion
proteins. Truncation mutations indicated that the complete VSV
AIS was required for fusion potentiation. Together, these data
support the hypothesis that the PreTM domain contributes to
VSV G-mediated membrane fusion activity and functions as a
fusogenic unit, yet the conserved aromatic residues seem to be
not essential for membrane fusion or infectivity in the context of
the assembled virus.
The membrane interactions of Ebola PreTMp-s, studied in a
vesicular system, supported the involvement of Ebola G PreTM
in membrane fusion (Fig. 1 and Ref. [31]).Thus, DNDNWW-
TGWRQWIPAGIG and DWGDAPNWRWNWGIIGTQ, repre-
senting the Ebola glycoprotein PreTM or a “scrambled” control
with a different hydrophobic-at-interface moment, respectively,
were characterized in a study that combined the assessment of
insertion into lipid monolayers, changes in intrinsic fluores-
cence and infrared spectroscopy [31]. Only the former bound
the membrane interface under equilibrium conditions and adop-
ted therein the predicted α-helical conformation. Following
a pattern similar to that previously described for HIV PreTMp,
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not affect membrane insertion, but it stimulated highly the
membrane-destabilizing capacity of Ebola PreTMp. The SPM
effect seemed to not arise from an intrinsic instability of the
vesicles, since the scrambled control sequence could not induce
leakage at any tested dose even though it interacted with lipo-
somes. The outcome of this study underscored the importance
of residue distribution within the Ebola PreTM sequence, spe-
cifically for the induction of membrane perturbations.
WW hydrophobicity analyses also put forward the existence
of FP and PreTM-like membrane-transferring domains in
SARS-CoV S sequence [38–40]. Membrane interactions of
S2 PreTM-representative KYEQYIKWPWYVW peptide were
subsequently characterized by means of CD, as well as in lipid
vesicle permeabilization assays [39]. Even though the structural
analyses indicated a low propensity for a defined secondary
structure, S2 PreTMp strongly partitioned into lipid membranes
and induced lipid vesicle permeabilization at peptide-to-lipid
mol ratios of 1:100. It was found that a scrambled YEWKWIY-
WYPVKQ peptide was severely impaired in its capacity to
induce vesicle permeabilization. Thus, partitioning of the wild-
type peptides into the lipid interface was sufficient to speci-
fically disorganize membrane integrity. A mechanism was pro-
posed according to which CoV S PreTM, aligned with the FP
and TMD during membrane apposition, would function to
perturb the target cell membrane, and also to provide a con-
tinuous track of hydrophobic surface. Assembly of this structure
would result in lipid-membrane fusion and subsequent viral
nucleocapsid entry.
A combined KD and WW analysis was also employed to
unravel Herpes simplex virus type-1 (HSV-1) glycoprotein H
(gH) sequences showing propensity to interact with membrane
interfaces [69,70]. A putative helical membrane-interacting
domain was identified just preceding the gH TMD [70]. A col-
lection of HSV-1 gH PreTMp-s was synthesized and character-
ized. It was found that STALLLFPNGTVIHLLAFDTQPVAAIA
(designated as pTM5) induced fusion of PC/cholesterol-containing
phospholipid vesicles, while SHVLTAPALTFNLTDFVPILALA-
GIQA, a scrambled version with same amino acid composition,
was defective in that activity. Interestingly, fusion activity in this
case was related to the capacity of the PreTMpwild-type to adopt a
β structure in contact with membranes. It was concluded that,
similar to amino-terminal FPs, structural flexibility, rather than the
rigid adoption of a particular secondary structure, might be a key
property of the HSV-1 PreTM domain as a fusogen.
5. Interfacial domains in viral membrane fission
Completion of the newly assembled virions budding at cell
membranes, known as “pinching-off” step, requires membrane
fission [71–73]. Conformational energy release occurs in this case
accompanied by multimerization of capsid proteins into spherical
surfaces that grow in contact with the internal membrane mono-
layer. As one of the best-studied examples, Gag polyprotein is the
main responsible for budding of immature HIV-1 particles, a
process involving a complex interplay between viral and cell-host
factors [1,2,72,74]. Gag-membrane association proceeds via theN-terminal myristoyl moiety of matrix (MA) domain coupled to
surface oligomerization [75–77]. Thus, Gag-membrane associa-
tion and assembly therein are likely to promote each other,
thereby driving the budding process.
Similarly, the minimal components needed to initiate, drive,
and complete the Rhabdovirus budding process are the con-
densed RNP core in association with the matrix (M) protein
[78]. However, in this case, in the absence of virally encoded
glycoproteins the number of virus particles released from in-
fected cells is significantly less than that made by WT virus.
Therefore, the envelope glycoprotein contributes to virus eg-
ress. Involvement of VSV G PreTM in this process was studied
using a series of recombinant ΔG-VSVs expressing chimeric
glycoproteins with truncated stem sequences [67]. The recom-
binant viruses having chimeras with 12 or more PreTM resi-
dues, and including the G protein transmembrane-cytoplasmic
tail domains, produced near-wild-type levels of particles. In
contrast, viruses encoding chimeras with shorter or no PreTM
sequences produced ca. 10- to 20-fold less. In line with its
putative association with the membrane interface, these authors
suggested that the VSV G PreTMmight promote virus release by
inducing positive membrane curvature at sites where virus
budding occurs.
Alphavirus 6K protein provides a further opportunity for the
study of interfacial domain activity in fission: firstly, this small
protein's sequence comprises a single PreTM-TMD motif [79],
and, secondly, 6K is not required for alphavirus budding, but
catalyzes the process [80], which allows recovery of budding
defective, but still infectious particles, upon cell transfection
with alphaviral replicon.
The budding of alphavirus particles is essentially promoted
by interaction of assembled nucleocapsids with the carboxy
domain of envelope glycoprotein E2 [73,81]. Despite the
association of the 6K protein with the plasma membrane and its
interaction with E1–E2 glycoproteins, very little 6K is incor-
porated into the budded virus particles. The N-terminal 6K
ectodomain encompasses two hydrophobic-at-interface seg-
ments that can mediate association of this sequence with the
external membrane monolayer [79]. Conservation of the inter-
facial 6K segments among divergent members of the Alphavirus
genus suggested a functional role for these motifs. Accordingly,
Sindbis virus (SV) 6K variants that contained substitutions inter-
fering with the capacity of the N-terminus to partition into mem-
branes without affecting KD hydrophobicity were obtained and
characterized. Electron microscopy of cells transfected with these
mutants disclosed accumulation at the plasma membrane of
otherwise morphologically normal virus particles, suggesting that
mutations introduced in the interfacial 6K sequence resulted in
impaired virus budding, likely due to inefficient pinching-off of
the assembled virus particles.
6. PreTM domains as targets for viral fusion inhibition
Since entry inhibition may block early stages of viral infec-
tion, the large conformational changes that are the energy source
for membrane fusion constitute an important target in develop-
ment of antiviral therapies. A paradigmatic case is that of the
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tor T-20 (enfuvirtide) is currently in use within the context of
rescue therapies active against multidrug resistant viruses [82].
This peptidic compound dominantly competes with gp41 helical
sequences for binding to hydrophobic grooves transiently
exposed at the ectodomain surface [83,84]. Thus, it is postulated
that T-20 blocks close contact between cell target and viral
membranes by preventing 6-HB formation.
In principle the functional domains that transmit 6-HB for-
mation energy into membranes, such as FP or PreTM, may
constitute alternative targets for antiviral development. Compel-
ling evidence that sustains suitability of FP function as a target
for inhibitor development has been again obtained in the case of
HIV-1. Early studies showed that oligopeptides homologous in
sequence to the FP were indeed capable of inhibiting gp41-
induced fusion [85–88]. Also supporting this view we have
recently identified gp41 inhibitors from a D-amino acid hexa-
peptide library, based on their capacity to block synthetic FPp in
vitro [89], and Munch et al. [90] have isolated a naturally pro-
duced oligopeptide targeting FP that was able to block HIV-1
infection. Thus, force-transmitting sequences emerge as alter-
native therapeutic targets [90,91].
The ability displayed by HIV-1 PreTMp to self-associate in
solution and membranes raised the possibility of PreTM homo-
oligomer formation at some stage during gp41-induced fusion
process [21,54]. It was inferred that PreTM homo-oligomer
formation might represent a target for potential inhibitors. This
hypothesis was tested analyzing PreTMp ability to interfere with
cell–cell fusion induced by HIV-1 envelope [21]. HIV-1
PreTMp inhibited gp41-induced fusion in a dose-dependent
manner with an apparent IC50 value of 577 nM. A W(1–3)A
mutant-like peptide unable to form homo-oligomers was used as
negative control and shown to be devoid of inhibitory effect. In
control experiments, neither of these two peptides inhibited
influenza hemagglutinin-mediated fusion implying that PreTMp
inhibitory effect was through its interaction with HIV envelope
protein, and not through its partitioning into cell membranes and
causing non-specific perturbations.
As mentioned before, a cognate 20-mer peptide derived from
FIV transmembrane glycoprotein PreTM, potently inhibited
viral infectivity in tissue culture (IC50≈4 nM) [66,92,93].
Antiviral activity of the leading PreTM sequence was found to
map to a short segment containing three conserved Trp residues.
Thus, further analyses focused on a derivative of eight amino
acids (770WEDWVRWI777), designated C8, which still dis-
played potent antiviral activity (IC50≈40 nM). C8 activity was
found to be dependent on conservation of the Trp motif, most
likely because these residues are responsible for its conform-
ational propensity. Furthermore, the retroinverso analogue of
this peptide (riC8) was shown to be effective in vivo, in
experiments demonstrating its ability to decrease mean viral
load when administered to chronically FIV-infected cats [92].
Albeit with an apparent lower affinity, peptides analogous
to the S2 subunit PreTM domain inhibited SARS-CoV pla-
que formation (inhibition by 40–70% at concentrations of
15–30 μM) [94]. In linewith these observations, HSV gHPreTM-
derived pTM4 and pTM5 peptides, modified by addition of a tailof lysine residues, were able to induce almost 100% inhibition of
HSV-1 infectivity at concentrations in the range of 100 μM [70].
Underscoring the specificity of the observed effect, the scrambled
version of pTM5 failed to inhibit infectivity under similar ex-
perimental conditions.
7. PreTM domains as targets for viral neutralization
Only two broadly neutralizing anti-HIV-1 antibodies isolated
from peripheral blood mononuclear cells of HIV infected non-
symptomatic patients have been described to react with gp41
[95,96]. These antibodies, designated as 2F5 and 4E10, recog-
nize epitopes within the conserved PreTM domain (reviewed in
Refs. [97–99], see also Fig. 1). 2F5 (662ELDKWAS668) and
4E10 (671NWFNIT676) core epitopes roughly span AIS and
the junction between the two PreTM interfacial subdomains,
respectively. Both of them have developed paratopes capable of
inserting into membrane interfaces, which putatively enables
them for recognition of membrane-inserted epitope sequences
[50,99–102]. Recent experimental work by our group sustains
specific recognition and blocking at membrane interfaces by
both antibodies [100,103], although following different mole-
cular mechanisms.
2F5 epitope appears to be an intrinsically flexible sequence
with access to different conformations depending on the mole-
cular context [34,104–109]. Crystallographic analysis of the
656NEQELLELDKWASLWN671 sequence in complex with
Fab 2F5 displays an extended conformation at the amino-
terminus, followed by two consecutive type I β-turns, which is
assumed to represent a defined, native-like gp41 structure [101].
Thus, it is inferred that Mab2F5will recognize with lower affinity
the α-helical conformation adopted by AIS upon partitioning into
the membrane interface [100]. In contrast, 4E10 antibody binds
PreTM epitope in the helical conformation that is also stable
at membrane interfaces [50,110,111] (Fig. 3).
MAb4E10 binding to the membrane-inserted epitope is
reflected by its capacity of blocking PreTMp-induced
membrane-restructuring effects (Fig. 5 and Ref. [103]). The
fact that membrane-restructuring blocking was dependent on
the presence of Chol suggests an adaptation of 4E10 antibody
for recognition of PreTM species residing at the virion
external membrane interface [103]. In contrast, 4E10 did not
greatly affect PreTMp-induced perturbations in PC:SPM
vesicles, most likely because PreTMp surface gets occluded
in the transmembrane pores responsible for permeabilization
of this type of vesicles [54,103]. Recognition at membrane
interfaces was also made evident by fluorescence microscopy
of lipid monolayers transferred onto glass coverslips [103]. In
these experiments, addition of Mab4E10 was shown to induce
surface clustering of PreTMp sequence in presence of Chol,
but not in its absence. It was concluded that a putative
mechanism of gp41 blocking might be based on Mab4E10
capacity for rendering cross-linked spikes incompetent for
fusion.
In summary, adopted conformation, aggregation state and
topology as affected by the envelope lipids may condition
Mab4E10 recognition of membrane-inserted PreTM epitope.
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In principle we cannot exclude the possibility that PreTM
folds as a component of globular ectodomains, either during
synthesis or at some stage before protein activation [112]. More
likely, PreTM is recruited into the 6-HB during progression of
the reaction mediated by class I fusion proteins. The observation
that 2F5 and 4E10 epitopes disappear concomitant to fusion
[113], i.e., coupled to 6-HB completion [114], would sustain
this notion in the case of HIV-1 gp41. In fact, Mab2F5
recognizes its epitope with lower affinity in the context of
synthetic 6-HB versions [115]. Thus, the absence of activity
observed in cell–cell fusion assays upon complete gp41 PreTM
ablation probably originates from the incapacity for coupling 6-
HB formation to membrane merger [45,65].
However, as disclosed by WW analyses, membrane-inserted
PreTM states exist with high probability (Fig. 1), a prediction
that seems to fulfill for native HIV Env glycoproteins incor-
porated into virions [36,37]. In the context of cells expressing
PreTM motifs, membrane-inserted PreTM states appear not to
be absolutely required for initiation and progression of fusion or
fission, their functional relevance being circumscribed to an
assisting effect on those processes. In support of this view, a
HIV-1 gp41 devoid of PreTM interfacial hydrophobicity is still
competent in opening small fusion pores [45] (see also Fig. 2),
ΔG-VSV is capable of inducing hemifusion on its own and also
of functioning as a potentiator of fusion induced by other viral
glycolproteins [68], and SV 6K catalyzes budding by promoting
the pinching-off step [79].
Differential surface increase of the external membrane mo-
nolayer upon insertion might provide a common molecular
mechanism to explain these catalytic effects [1,2]. Monolayer
surface imbalance might contribute to membrane deformation
and bending (positive curvature) at the points of virus budding.
It is inferred that imparting positive curvature to distal trans-
monolayers engaged in pinching-off will promote completion
of the process [1,116]. More difficult to envisage is how posi-
tive curvature applied to contacting cis-monolayers might pro-
mote fusion. A possibility is that fusion is actually restrained by
PreTM-induced positive curvature (committed state) until the
process is activated. In such a case, extracting PreTM out of the
interface, for instance by recruiting it into the growing 6-HB
structure, might differentially reduce the surface of contacting
monolayers, thereby stimulating fusion.
More specific structural and functional roles that might
explain the high degree of HIV-1 PreTM sequence conserva-
tion, can be related to assembly, maturation and fusion activa-
tion of virions. These roles are likely to depend on its folding as
an interfacial α-helix, which binds Chol, self-assembles in a raft
environment, and is endowed with the capacity of restructuring
this type of membranes. Indeed, most if not all PreTM mutants
described by Salzwedel et al. dramatically affected incorpora-
tion of glycoprotein into virions [44]. These authors were the
first to propose that one possible role for the conserved tryp-
tophan residues in enhancing the incorporation of glycoprotein
into virions could involve an interaction with cholesterol. Sub-
sequently reported experimental evidence supports this notion[61–64]. Such interactions could facilitate the enrichment of
glycoprotein within plasma membrane raft-domains through
which the virus might bud [59], or even be employed in gene-
rating Chol-rich domains [62,117]. Thus, PreTMmight function
as a raft-sensor to pilot Env protein to budding sites during viral
assembly. Furthermore, specific folding and self-association
within a Chol-enriched raft environment might be crucial for
gp41 function [56,118–121].
The low spike density existing in the virion envelope (≈10–20
spikes and ≈300,000 lipids, see Refs. [35,58]) might in part
account for HIV-1 PreTM sequence conservation. It is tempting to
speculate that clusters of inserted PreTMs might be initially
responsible for the induction of local positive curvature within
laterally segregated areas of the external viral membrane mono-
layer. As a matter of fact, electron tomography of intact virions
reveals spikes distributed forming clusters of at least seven
members [36], and clusters of rod-shaped proteins at the focal
points where the actual membrane merger develops [122]. Within
these distinct areas, monolayer intrinsic curvatures could hypo-
thetically change their sign upon PreTM desorption, thus faci-
litating fusion pore opening.
An alternative not exclusive option is that PreTM acts as an
FP-like fusogenic sequence in laterally segregated PC-Chol
domains, by promoting and/or stabilizing fusion pore archi-
tecture [29,30,123]. Sustaining this notion HIV-1 PreTMp
partitions into POPC or POPC:SPM membranes but is only
fusogenic when Chol is added to the lipid composition (Fig. 4
and Ref. [54]). Chol requirement actually supports that the
membrane-restructuring processes observed in liposomes are
indeed bona fide reflection of a gp41 PreTM physiological role
[118,121] (Fig. 4). Moreover, PreTMp membrane activity is
affected by blocking mutations (Fig. 2), occurs at membrane
doses relevant for spike density (Fig. 4) and is inhibited by
neutralizing antibodies (Fig. 5). Attending to data reported in
the literature, such an intrinsic membrane-perturbing activity
could be a general feature of viral PreTMs [21,29–31,39–41,
54,60,70,79,124–126]. However, structure–function requi-
rements may vary depending on the virus family, and adoption
of an interfacial helical conformation seems not to be a pre-
requisite for membrane-disruption induced by the different
PreTMp-s [30,39,70,124].
The close proximity to the membrane surface of TMD-linked
PreTM implies an effective concentration high enough as to
push partitioning equilibrium towards membrane-inserted spe-
cies. Even for sequences that are not specially enriched in aro-
matic residues, a mild degree of hydrophobicity together with
access to a defined secondary structure upon partitioning, is
likely to suffice for stable insertion into the membrane interface.
Thus, there arises the question of long aromatic-rich PreTM
domains as representing an adaptive improvement in the context
of viral infection strategies. Again, HIV-1 provides an example
of the way this adaptation might operate.
Most surface of native gp41 in virions remains inaccessible
to neutralizing antibodies due to steric occlusion by surface
gp120 subunit and/or homo-oligomerization [97–99]. Just the
MPER stem region is potentially exposed to solvent [112,127].
Thus, the probability of neutralization by binding to MPER
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i) limiting the envelope spike number (i.e., reduction of binding-
sites and concomitant avidity decrease), and ii) occludingMPER
epitopes into the interface of the viral external membrane mo-
nolayer (affinity decrease). Long aromatic-rich PreTM might
play a central role in driving both effects. In one hand, as
discussed before, its capacity to self-associate at the raft-like
membrane surface would buttress the reduction of the number of
spikes at the viral surface required for fusion. On the other, its
high degree of hydrophobicity-at-interface ensures embedding
of stem epitope sequences into the membrane, thereby occluding
key residues for recognition and/or inducing membrane-specific
secondary structure.
Indeed, insertion into membrane interfaces, and even phos-
pholipid recognition therein, have been postulated to correlate
with the broadly neutralizing capacity of anti-gp41 2F5 and
4E10 antibodies [128–132]. Mab4E10 is capable of binding
and blocking PreTMp in membranes at peptide-to-lipid ratios
relevant for the low spike virion density [100,102,103]. We
have proposed a mechanism of neutralization by 4E10 based on
its capacity to cross-link interfacial PreTM sequences [103].
According to that mechanism 4E10 would disorganize the spike
clusters required for fusion initiation. Further studies of the
mechanisms governing membrane-inserted epitope recognition
will lead to new insights regarding the know-how to design
effective anti-HIV-1 vaccines.
9. Note added to proofs
The structure recently reported by Sun et al. (Immunity 28
(2008), 52-63) supports the bipartite nature of HIV-1 AIS-PreTM
inserted at the membrane interface.
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